Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial

Peer Review reports

Original Submission
10 Aug 2020	Submitted	Original manuscript
29 Sep 2020	Reviewed	Reviewer Report
2 Oct 2020	Reviewed	Reviewer Report
25 Oct 2020	Author responded	Author comments - Dena Firouzabadi
Resubmission - Version 2
25 Oct 2020	Submitted	Manuscript version 2
13 Nov 2020	Author responded	Author comments - Dena Firouzabadi
Resubmission - Version 3
13 Nov 2020	Submitted	Manuscript version 3
Publishing
17 Nov 2020	Editorially accepted
11 Jan 2021	Article published	10.1186/s12885-020-07652-0

Back to article page